CME Group price target raised to $279 from $263 at Barclays

Barclays analyst Benjamin Budish raised the firm’s price target on CME Group (CME) to $279 from $263 and keeps an Equal Weight rating on the shares. as part of a Q1 preview for the brokers, asset managers and exchanges. With volatility “in full swing,” mergers and initial public offering pipelines are likely to see further delays, the analyst tells investors in a research note. The firm says that while trading activity was generally robust despite a slowdown in crypto, brokers “now face a more intense headwind from a lower in-period Fed funds and futures curve.”